Epivir Hbv is an oral antiviral medication indicated for the treatment of chronic hepatitis b infection. It belongs to the class of nucleoside reverse transcriptase inhibitors that block the viral polymerase enzyme. By being phosphorylated intracellularly the drug is converted to an active triphosphate form that competes with natural deoxyguanosine triphosphate for incorporation into viral dna. This incorporation leads to chain termination and prevents further viral genome elongation. The active metabolite also inhibits the transcription of viral mrna and the assembly of new viral particles. The resulting reduction in viral replication lowers serum hepatitis b virus dna levels and improves liver enzyme concentrations over time. Clinically the medication is used to slow disease progression in patients with chronic infection who are eligible for therapy.

Epivir Hbv is an antiviral medication containing lamivudine that is used to treat chronic hepatitis b virus infection. It works by inhibiting the viral dna polymerase enzyme, preventing the synthesis of viral dna. This inhibition disrupts the replication cycle of the hepatitis b virus, reducing viral load in the bloodstream. By lowering the amount of active virus, the medication helps the immune system control the infection more effectively. Epivir Hbv is classified as a nucleoside reverse transcriptase inhibitor, which means it mimics the building blocks needed for viral dna formation. Once inside infected liver cells, the drug is phosphorylated to its active triphosphate form, enhancing its ability to block polymerase activity. The combined effect of polymerase inhibition and reduced viral replication leads to improved liver enzyme levels and slower disease progression.

Naphtha may cause headache. It can lead to nausea. Some people experience fatigue. Skin rash is a possible reaction. Liver function tests may show abnormal results. Mild dizziness sometimes occurs. Rarely changes in taste perception have been reported.

Epivir Hbv may cause nausea or vomiting in some patients. Headache is a commonly reported symptom. Some individuals experience fatigue or dizziness. Rarely, liver enzyme levels can increase. Skin rash or itching may develop during treatment. Most side effects are mild and transient.